| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | S01EE01 |
| UNII | 6Z5B6HVF6O |
| EPA CompTox | DTXSID1041057 |
| InChI Key | GGXICVAJURFBLW-CEYXHVGTSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C26H40O5 |
| Molecular Weight | 432.6 |
| AlogP | 4.19 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 13.0 |
| Polar Surface Area | 86.99 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 31.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Prostanoid FP receptor agonist | AGONIST | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Other ion channel
Pore-forming toxins (proteins and peptides)
|
- | - | - | - | 11.4 |
|
Protein: Prostanoid FP receptor Description: Prostaglandin F2-alpha receptor Organism : Homo sapiens P43088 ENSG00000122420 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 6384 |
| ChEMBL | CHEMBL1051 |
| DrugBank | DB00654 |
| DrugCentral | 1551 |
| FDA SRS | 6Z5B6HVF6O |
| Human Metabolome Database | HMDB0014792 |
| Guide to Pharmacology | 1961 |
| KEGG | D00356 |
| PubChem | 5311221 |
| SureChEMBL | SCHEMBL24698 |
| ZINC | ZINC000012468792 |